Link Pharma Chem Legal & Regulatory

Link Pharma Chem Other Announcement

Link Pharma Chem Ltd filed a periodic non-applicability notice for Reg 23(9) RPT disclosure. The company's paid-up capital and net worth fall below LODR thresholds, so no disclosure is required.

Link Pharma Chem Q2 FY27 Results: Net Loss of ₹0.2 Cr

Link Pharma Chem approved unaudited results for the quarter and half year ended 30 September 2026. Revenue was Rs.533.13 Lakh with a loss of Rs.22.31 Lakh for the quarter.

Key figure

Net loss ₹0.2 Cr

Link Pharma Chem Board Meeting Date

Link Pharma Chem's board meets on 3 November 2026 to approve unaudited half-year results. The trading window stays closed until results are declared.

Link Pharma Chem Other Announcement

Link Pharma Chem Ltd has filed its quarterly shareholding pattern as mandated by SEBI regulations. This routine disclosure provides the updated ownership structure for the company.

Link Pharma Chem Management Change

Link Pharma Chem Limited has announced the re-appointment of Rishikesh Thakur and Satish G Thakur as Executive Directors for a term of 36 months each.

Link Pharma Chem Annual General Meeting

Link Pharma Chem Ltd. held its 41st Annual General Meeting on August 20, 2026, where shareholders transacted various ordinary and special business items.

Honda India Power Products Legal & Regulatory

Honda India Power Products received a customs Show Cause Notice for FY 2019-2020, with a hearing set for November 11, 2026. No financial or operational impact expected.

Schneider Electric Infrastructure Legal & Regulatory

Schneider Electric Infrastructure received a GST appellate order rejecting its appeal on a ₹3.38 Crore tax and penalty demand. The company sees no material financial impact.

Value

₹3.38 Cr

Nephrocare Health Services Legal & Regulatory

Nephrocare's Uzbek subsidiary won a court ruling invalidating a ₹14.79 crore tax demand. The tax department must reconsider the audit, and the decision remains appealable.

Value

₹14.79 Cr

Supriya Lifescience Legal & Regulatory

Supriya Lifescience disclosed that its General Manager, Sales & Marketing, was granted bail in an NDPS Act case. The company says the order has no material impact.

Muthoot Finance Legal & Regulatory

Muthoot Finance disclosed a GST Department search and seizure at its Registered Office, conducted October 29-30, 2026. The company states business operations remained unaffected and it is cooperating fully.

Praveg Legal & Regulatory

Praveg received a SEBI penalty order of ₹2 lakh over amalgamation-related non-compliance. The penalty is payable within 45 days.

Value

₹0.02 Cr